$1.240
-0.029 (-2.37%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
APVO Prediction & Forecast by Similar Chart Analysis
Alphio's APVO stock price prediction model matches the current Aptevo Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.15 (+0.92%). The 1-week path is $1.15 (+1.10%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Aptevo Therapeutics Inc Stock?
Aptevo Therapeutics is not a good buy right now due to its extremely low RSI of 19.049, indicating oversold conditions, and a staggering year-to-date change of -86.80%. The stock has significant financial challenges, including a reported EPS of -40.11, which is far below expectations. The main risk is its forward P/E of 3.8895, which suggests that while the stock may be undervalued, the company is struggling to generate revenue, as evidenced by total revenue of $0.00 for multiple quarters. The lack of positive cash flow and ongoing losses indicate that investors should be cautious before considering a purchase.
APVO stock price ended at $1.24 on Friday, after losing -2.37%
Aptevo Therapeutics Inc (APVO) last closed at $1.135, losing -8.46%. These facts feed the 1-day and 1-week APVO price prediction above.
Analyst Consensus
Aptevo Therapeutics Inc (APVO): 1 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Aptevo Therapeutics Inc (APVO) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches APVO, ranked by similarity.
Seasonality analysis for APVO
Historically the probability of a positive November return for APVO is 0.00%. January offers the highest probability of a positive month at 16.39%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for APVO
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $2.45 | $2.90 | $2.93 | +155.52% |
| Dec 2026 | $2.54 | $2.81 | $3.29 | +147.49% |
In 2026, Aptevo Therapeutics Inc (APVO) is projected to range from $2.45 to $3.29.
Aptevo Therapeutics Inc 2026 monthly forecast
In Nov 2026, Aptevo Therapeutics Inc is projected to average $2.90, with a low of $2.45 and high of $2.93.
In Dec 2026, Aptevo Therapeutics Inc is projected to average $2.81, with a low of $2.54 and high of $3.29.
Related articles
- CPI Report and the Stock Market: How to Read October 2026 Inflation Data Before the Fed DecidesOctober 2026 CPI lands Nov 10 with no year-over-year number and Fed hike odds near 80%. Learn how to read CPI, which stocks react, and how to plan for it.
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.